InvestorsHub Logo
Followers 32
Posts 3389
Boards Moderated 0
Alias Born 08/04/2009

Re: None

Thursday, 12/14/2017 11:01:05 AM

Thursday, December 14, 2017 11:01:05 AM

Post# of 1721
4 Buy ratings, 0 Sell and 2 Hold.
Among 6 analysts covering Insys Therapeutics (NASDAQ:INSY), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Insys Therapeutics had 22 analyst reports since August 4, 2015 according to SRatingsIntel.
https://presstelegraph.com/can-insys-therapeutics-incorporated-nasdaqinsys-tomorrow-be-different-the-stock-had-decline-in-shorts/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.